Skip to main content drug discovery and development magazine home news pharma/biotech news cros/cmos legal/regulatory life science supplier news drug pipeline technologies biochemicals/kits cell biology chromatography immunochemicals instruments lab equipment mass spectrometry microscopes molecular biology software services topics disease research genomics/proteomics drug discovery preclinical studies drug safety clinical trials formulation/delivery regulations cro directory resources events print archive vital signs white papers multimedia webcasts videos free subscriptions log in register news drug boosts platelets in immune thrombocytopenic purpura patients fri, 03/20/2009 - 8:12am get today's drug discovery & development headlines and news - sign up now! generic viagra me uk kamagra Patients suffering from a blood disorder (chronic immune thrombocytopenic purpura, also known as itp) that prevents proper clotting have the option of a new medication that may improve their health. http://nationalityinworldhistory.net/bsh-buy-viagra-online-no-prescription-xr/ Promacta (eltrombopag) was granted accelerated approval by the us food and drug administration in november 2008 for the treatment of thrombocytopenia in patients with chronic immune (idiopathic) thrombocytopenic purpura who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy. buy viagra Promising results of an international, multicenter phase 3 clinical trial, led by newyork-presbyterian/weill cornell researchers, were the basis of this approval. 50 mg viagra dosage 'findings from the new study are very encouraging, and i believe this treatment is an effective option for all patients suffering from chronic itp,' says dr. viagra without prescription James bussel, principal investigator of the study; attending pediatrician and director of the program for platelet disorders at newyork-presbyterian hospital/weill cornell medical center; and professor of pediatrics, and professor of pediatrics in medicine at weill cornell medical college. 50 mg viagra dosage The phase 3 study tested 114 subjects, who were all 18 years and older, with at least six months of history with itp and with low-platelet counts of 30,000 per microliter (âµl) of blood (normal range is 150,000 to 400,000). order viagra The subjects were split into two groups: two-thirds were in an experimental group that received the standard of care with the addition of 50mg of eltrombopag, and a control group received the standard of care and a placebo pill. cheap viagra online By the end of the 43-day testing peri. how to get a viagra prescription online viagra online without prescription